Safety and efficacy of statins
Lancet
.
2017 Mar 18;389(10074):1097.
doi: 10.1016/S0140-6736(17)30713-4.
Authors
John Abramson
1
,
Harriet G Rosenberg
2
,
Nicholas Jewell
3
,
James M Wright
4
Affiliations
1
Harvard Medical School, Boston, MA 02115, USA. Electronic address: john_abramson@hms.harvard.edu.
2
Department of Social Science, Faculty of Liberal Arts and Professional Studies, York University, Toronto, ON, Canada.
3
Division of Biostatistics, School of Public Health Department of Statistics, University of California, Berkeley, CA, USA.
4
Departments of Anesthesiology, Pharmacology and Therapeutics and Medicine, University of British Columbia, Vancouver, BC, Canada.
PMID:
28322813
DOI:
10.1016/S0140-6736(17)30713-4
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Treatment Outcome
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors